Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

374 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Glycomics as prognostic biomarkers of hepatocellular carcinoma: A systematic review.
Somers N, Butaye E, Grossar L, Pauwels N, Geerts A, Raevens S, Lefere S, Devisscher L, Meuris L, Callewaert N, Vlierberghe HV, Verhelst X. Somers N, et al. Among authors: geerts a. Oncol Lett. 2024 Oct 23;29(1):24. doi: 10.3892/ol.2024.14769. eCollection 2025 Jan. Oncol Lett. 2024. PMID: 39530005 Free PMC article.
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis.
Harrison SA, Bedossa P, Guy CD, Schattenberg JM, Loomba R, Taub R, Labriola D, Moussa SE, Neff GW, Rinella ME, Anstee QM, Abdelmalek MF, Younossi Z, Baum SJ, Francque S, Charlton MR, Newsome PN, Lanthier N, Schiefke I, Mangia A, Pericàs JM, Patil R, Sanyal AJ, Noureddin M, Bansal MB, Alkhouri N, Castera L, Rudraraju M, Ratziu V; MAESTRO-NASH Investigators. Harrison SA, et al. N Engl J Med. 2024 Feb 8;390(6):497-509. doi: 10.1056/NEJMoa2309000. N Engl J Med. 2024. PMID: 38324483 Clinical Trial.
Clinical management of liver cyst infections: an international, modified Delphi-based clinical decision framework.
Duijzer R, Bernts LHP, Geerts A, van Hoek B, Coenraad MJ, Rovers C, Alvaro D, Kuijper EJ, Nevens F, Halbritter J, Colmenero J, Kupcinskas J, Salih M, Hogan MC, Ronot M, Vilgrain V, Hanemaaijer NM, Kamath PS, Strnad P, Taubert R, Gansevoort RT, Torra R, Nadalin S, Suwabe T, Gevers TJG, Cardinale V, Drenth JPH, Lantinga MA. Duijzer R, et al. Among authors: geerts a. Lancet Gastroenterol Hepatol. 2024 Sep;9(9):884-894. doi: 10.1016/S2468-1253(24)00094-3. Epub 2024 Jun 12. Lancet Gastroenterol Hepatol. 2024. PMID: 38878785 Review.
External validation of the IAIHG autoimmune hepatitis response criteria in a multicentric real-world cohort.
Grossar L, Raevens S, Van Steenkiste C, Colle I, De Vloo C, Orlent H, Schouten J, Gallant M, Van Driessche A, Lefere S, Devisscher L, Geerts A, Van Vlierberghe H, Verhelst X. Grossar L, et al. Among authors: geerts a. JHEP Rep. 2024 Jun 23;6(9):101149. doi: 10.1016/j.jhepr.2024.101149. eCollection 2024 Sep. JHEP Rep. 2024. PMID: 39247177 Free PMC article.
Elafibranor, an Agonist of the Peroxisome Proliferator-Activated Receptor-α and -δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening.
Ratziu V, Harrison SA, Francque S, Bedossa P, Lehert P, Serfaty L, Romero-Gomez M, Boursier J, Abdelmalek M, Caldwell S, Drenth J, Anstee QM, Hum D, Hanf R, Roudot A, Megnien S, Staels B, Sanyal A; GOLDEN-505 Investigator Study Group. Ratziu V, et al. Gastroenterology. 2016 May;150(5):1147-1159.e5. doi: 10.1053/j.gastro.2016.01.038. Epub 2016 Feb 11. Gastroenterology. 2016. PMID: 26874076 Free article. Clinical Trial.
374 results